This webinar will be hosted live and available on-demand

Thursday, January 26, 2023 
11:30 AM Eastern Time 

Monoclonal antibody therapies are promising treatments for chronic disorders because they identify specific disease-causing molecules and train the immune system to clear them from the body. However, designing effective antibody-based therapeutics that elicit the appropriate response in patients is challenging. Scientists rely on cutting-edge technologies to develop and test every aspect of their candidate therapeutics. 

In this webinar brought to you by The Scientist’s Creative Services Team, Gestur Vidarsson and Pontus Nordenfelt will highlight how antibodies modulate immune responses in a disease context, and discuss what is left to learn about functional antibody therapeutic development.

Topics to be covered 

  • How naturally regulated variations of N-linked glycans in the IgG constant region influence effector functions
  • Antibacterial antibodies as an example of developing and understanding functional antibodies
Nikolai Slavov, PhD

 Gestur Vidarsson, PhD
Senior Researcher
Immunoglobulin Research Laboratory
Department of Experimental Immunohematology
Sanquin Research

Professor of Immunoglobulin Biotherapeutics
Department of Pharmaceutics
Utrecht Institute for Pharmaceutical Sciences (UIPS)
Utrecht University

Pontus Nordenfelt, PhD

Pontus Nordenfelt, PhD 
Senior Lecturer, Associate Professor

Division of Infection Medicine
Department of Clinical Sciences
Faculty of Medicine
Lund University 

Sponsored by